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ABSTRACT
Postpartum depression (PPD) is one of the most common mental health conditions, affecting
one in seven women during their reproductive years (American College of Obstetricians and
Gynecologists [ACOG], 2018). The purpose of this evidence-based practice (EBP) project was
to improve screening and management of PPD using the Edinburgh Postnatal Depression Scale
(EPDS) screening tool and a protocol for appropriate treatment and follow up care for PPD. A
protocol was created by the project leader with information on screening and diagnosis, follow
up, and treatment for PPD. The protocol also included information on how to assess for suicidal
and/or homicidal ideation in women with PPD. Women who were seen for a 2- or 6-week
postpartum visit (n = 18) were recruited at a women’s health clinic in Northwest Indiana to
participate in the project. Data collection was done on a pre-intervention group to determine if
the EPDS was used prior to implementation of the project. The post-intervention group (n = 18)
received screening with the EPDS at their postpartum visit. The number of participants
screened with the EPDS comprised the primary outcome and was measured as a frequency.
The secondary outcome of detection rates of PPD was measured by EPDS scores of 10 or
greater. Data were analyzed using a Mann-Whitney test, chi-square test, and a simple linear
regression to determine if demographic variables had an impact on EPDS scores as another
secondary outcome. The primary outcome was met with a 50.3% increase in screening rates
using the EPDS. The secondary outcome was also met with a 100% increase in detection rates
of postpartum depression from using the EPDS. The data analysis concluded that the variable
of age was statistically significant and had an impact on EPDS scores. Findings from this project
may be used in practice to ensure appropriate screening and management for PPD is being
implemented.
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CHAPTER 1
INTRODUCTION
Background
Postpartum depression is a common mood disorder occurring up to one year after giving
birth with a variety of life-altering symptoms (Kurtz et al., 2017). The symptoms can include
depressed mood, decreased pleasure in activities, significant change in appetite and/or sleep,
agitation, fatigue, feelings of hopelessness or worthlessness, and recurring thoughts of death or
suicide (Kurtz et al., 2017). Postpartum depression is one of the most common medical
conditions, affecting as many as one in seven women (ACOG, 2018). The initial onset of
depression in women peaks during reproductive-age years (ACOG, 2018). Postpartum
depression occurs in the postpartum period, which can be defined as the first 12 months
following birth (ACOG, 2018). The symptoms of postpartum depression not only affect women,
but their infants and families as well.
A single cause for postpartum depression cannot be identified, however it may be
attributed to physical and emotional changes that occur during and after pregnancy (Mayo
Foundation for Medical Education and Research [MFMER], 2018). Hormone levels drop
dramatically after giving birth and this drop in estrogen and progesterone may contribute to
postpartum depression (MFMER, 2018). Sleep deprivation and feelings of anxiety and being
overwhelmed while caring for a newborn can also contribute (MFMER, 2018). Risk factors for
postpartum depression include a history of depression, a diagnosis of bipolar disorder,
postpartum depression with previous pregnancy, family history of depression, stressful life
events, having a child with special needs, having multiples, inadequate support system,
financial problems, or an unplanned/unwanted pregnancy (MFMER, 2018).
Postpartum depression is often not detected for several reasons. Very few women report
symptoms to their health care providers. Symptoms such as changes in sleep or appetite are
not always recognized as depression symptoms and are attributed to normal changes in the
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postpartum period (ACOG, 2018). Women are also reluctant to report symptoms due to feelings
of shame and the stigma associated with postpartum depression (ACOG, 2018; Learman,
2018). In a study that addressed the recognition of postpartum depression, less than 20% of
women who were diagnosed with postpartum depression had previously reported their
symptoms to a health care provider (ACOG, 2018). Perinatal depression is the most frequently
under-diagnosed complications associated with pregnancy (Registered Nurses’ Association of
Ontario [RNAO], 2018). In addition, health care providers do not always follow evidenced-based
practice and there is a lack of screening for postpartum depression (Austin & Highet, 2017;
Kendig et al., 2017; Learman, 2018). This lack of screening may be attributed to lack of time
and education, the inability to identify an appropriate screening tool and/or interpreting
screening results, poor referral pathways, and inadequate community mental health services
(Austin & Highet, 2017; Learman, 2018). When there are no plans in place for obstetric
practices to effectively respond to positive screenings for postpartum depression, less than 20%
of women who screen positive receive mental health care (Moore Simas et al., 2018). If left
undetected and untreated, postpartum depression can have devastating effects on women, their
infants, and their families. Symptoms of postpartum depression can lead to serious health
problems, including death (ACOG, 2018; Austin & Highet, 2017). Death from maternal suicide
exceeds postpartum hemorrhage and hypertensive disorders as a cause of maternal mortality
(ACOG, 2018). It is extremely important for health care providers to provide screening and
appropriate follow up to detect and treat postpartum depression. Healthy People 2030 has set a
goal to improve the proportion of women screened for postpartum depression at their
postpartum check-up because of this importance (United Health Foundation, 2021).
Data Supporting Need for the Project
Global, National, Regional, and State Data
Approximately 10% of pregnant women and 13% of postpartum women will experience a
mental illness (most likely depression) globally (RNAO, 2018). Perinatal depression is a notable
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cause of disease burden globally as well (RNAO, 2018). Australian studies report prevalence of
postpartum depression in a 12-month period as one in six women (Austin & Highet, 2017).
Financial costs associated with postpartum depression in Australia were estimated at 60.68
million dollars annually. The Canadian Maternity Experience Survey reported a rate of 8.46% of
postpartum depression, measured by the Edinburgh Postnatal Depression Scale (EPDS). The
United States has a high incidence of perinatal depression, with as many as one in seven to 10
pregnant women and one in five to eight postpartum women with a depressive disorder (Van
Niel & Payne, 2021). Perinatal depression affects 10 to 20% of women in the United States
(ACOG, 2018; Kurtz et al., 2017; RNAO, 2018); this percentage equates to more than half a
million women with perinatal depression each year (Van Niel & Payne, 2021). In the state of
Indiana, 18.1% of women reported postpartum depressive symptoms in 2018 (Centers for
Disease Control and Prevention, 2021). In the last three years, Indiana’s rates for postpartum
depression have trended upward from 11.9% to 13.2% from 2017 to 2020 (United Health
Foundation, 2021). This percentage does not account for the many women who do not report
symptoms to their health care providers (ACOG, 2018).
Clinical Agency Data
The women’s health clinic is in need of a practice change regarding screening and follow
up for postpartum depression. Prior to project implementation, the obstetrician/gynecologist
(OB/GYN) and nurse practitioner providing care to women in the postpartum period did not have
a consistent method for screening for postpartum depression. The provider asked patients
simple questions pertaining to feelings of depression and anxiety at the patient’s postpartum
check-up. These questions included asking the patient if she is feeling sad, anxious, or
depressed. This check-up occurred at two and six weeks postpartum for women who delivered
via cesarean section and at six weeks for women who delivered via vaginal delivery. If the
patient answered yes to these questions, the EPDS was administered. Patient charts for women
who delivered between February 23rd, 2021, and July 7th, 2021, were examined to determined
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what type of screening was done for postpartum depression. Encounter notes from each patient
chart were assessed. Of the 39 patients who were seen for a postpartum check-up at 2- or 6weeks, only one patient was screened with the EPDS. According to the encounter note, this one
patient voiced concerns and feelings of depression at her postpartum visit, which took place at 4
weeks postpartum. The OB/GYN then screened the patient with the EPDS and diagnosed the
patient with postpartum depression based on the score and clinical judgement of symptoms,
however a specific score or symptoms were not addressed in the encounter note. The
encounter note mentioned that the patient was treated for postpartum depression with
pharmacologic therapy, a specific medication was not mentioned and follow up after this
positive screening was not given. The other 38 patients were asked questions by the OB/GYN
and were not administered the EPDS tool. There were no other diagnoses of postpartum
depression between the 38 women who were screened with the questions asked. Based on this
clinical data, the percentage of patients screened with the EPDS and diagnosed with postpartum depression in a 4-and-a-half-month period was 2.5% of patients.
Purpose of the Evidence-Based Practice Project
Purpose Statement and PICOT Question
The purpose of this EBP project was to improve screening and management of
postpartum depression through the use of the EPDS screening tool and appropriate follow up
care. The goal of the project was to improve timely detection and treatment of postpartum
depression in an obstetrical care setting. The project addressed the following PICOT question:
Among women who are 2- to 6-weeks postpartum, how does the implementation of a screening
tool (EPDS) and follow up protocol in a women’s health care setting affect screening rates and
detection of postpartum depression, compared to current practice, over a 19-week period?
EBP Project Description
The project intervention was the use of the EPDS tool for all postpartum women at their
2- or 6-week postpartum visit to screen for postpartum depression. A protocol was put in place
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to ensure all providers were following evidence-based practice regarding screening and follow
up, including treatment for postpartum depression. The protocol included when to screen for
postpartum depression and with what tool and how to intervene with a positive screening,
including appropriate follow up visits and referral to mental health, if necessary, alternative
therapy, and pharmacologic treatment. The registered nurse (RN) at the clinic was to administer
a paper form of the EPDS tool to all women at their 2- or 6-week postpartum visit. However, due
to issues with staffing, the receptionists at the front desk administered the EPDS form. The
score of the EPDS was then entered into the patient’s chart manually by the RN. With a score of
10 or greater, the OB/GYN or nurse practitioner addressed the results with the participant and
inquired about specific symptoms the patient might have been experiencing. Following this
interview with the participant, a treatment plan was discussed as specified in the protocol.
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CHAPTER 2
EBP MODEL AND REVIEW OF LITERATURE
Evidence-based Practice Model
Overview of EBP Model
The model chosen for this EBP project was the Johns Hopkins Nursing Evidence-Based
Practice model (JHNEBP). The JHNEBP model is well organized into different stages of the
PET process, which consists of the practice question, evidence, and translation (Melnyk &
Fineout-Overholt, 2019). The goal of the model is to incorporate evidence-based research and
practice into the clinical setting. The JHNEBP fits well with this EBP project because the model
applies to clinical, learning, and operational questions in any nursing setting. Therefore, the
JHNEBP model was applied to the clinical inquiry or question regarding postpartum depression
and screening for this project. The clinical site chosen for this project did not follow evidencebased practice recommendations regarding postpartum depression screening prior to
implementation of this project. A practice question was identified with the project site facilitator,
based on the clinic’s needs. In order for evidence-based research and practice to be
implemented into the clinical site, the next steps of the JHNEBP needed to be followed. These
steps included identifying key stakeholders, a literature search and appraisal of evidence,
synthesizing the evidence, and making specific recommendations for change based on the
evidence (Melnyk & Fineout Overholt, 2019). The final step included constructing a plan to
implement recommendations into practice and evaluating the outcomes and reporting them to
key stakeholders (Melnyk & Fineout Overholt, 2019). Refer to Figure 2.1 for an illustration of the
JHNEBP model. Please note that permission was granted to use the JHNEBP model from the
Johns Hopkins Hospital/Johns Hopkins University School of Nursing.
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Figure 2.1
JHNEBP Model
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Literature Search
Sources Examined for Relevant Evidence
The Joanna Briggs Institute (JBI), TRIP, CINAHL, PsycINFO and MEDLINE with Full
Text databases were utilized for this literature search. The same keywords and phrases were
searched across all databases to yield similar results. Several different keywords and phrases
were trialed within each database for the literature search and with the help of the Research
Services Librarian, final keywords and phrases were chosen. The keywords and phrases
included postpartum depression, screen*, detect*, diagnos*, obstetric*, “primary care”, “primary
health care”, and “primary healthcare”. Quotations were used within the TRIP, MEDLINE,
PsycINFO, and CINAHL databases for the phrase postpartum depression and quotations were
used within the CINAHL, MEDLINE, and PsycINFO databases for the phrases primary care,
primary health care, and primary healthcare. The limiter of the year 2016 to current was applied
for all searches. The limiter of guidelines was applied in the TRIP database search and limiters
of English language, scholarly peer reviewed journals, and female gender were applied in the
CINAHL, MEDLINE, and PsycINFO database searches. Organizational websites pertinent to
postpartum women and depression were also searched including the American College of
Obstetricians and Gynecologists (ACOG), the Agency for Healthcare Research and Quality
(AHRQ), and the Association of Women’s Health, Obstetric and Neonatal Nurses (AWHONN).
The literature search was reviewed and signed off by the Research Services Librarian and
deemed adequate for this project’s literature search and review. A more recent literature search
was conducted in February of 2022 to search for new evidence, however no relevant new
literature was found.
Inclusion and exclusion criteria were considered for the selection of studies. Studies
were chosen that focused on detection of depression in postpartum women and follow up care
in the postpartum period. Follow up care in the postpartum period includes further assessment
based on initial screening, management of postpartum depression by the women’s health
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specialist, or referral to a mental health specialist. The study also needed to address screening
tools for detection of postpartum depression. Studies were excluded if they focused primarily on
pharmacologic and alternative treatment for prevention or treatment of postpartum depression.
If studies did not include women in the postpartum period or focused on depression in
fatherhood, they were excluded as well. Higher levels of evidence were chosen including
systematic reviews, evidence summaries, and clinical practice guidelines (CPGs). Expert
opinions were also chosen from ACOG and AWHONN, which are accredited organizations.
The number of results yielded from each database search can be seen in the PRISMA
flow chart on the following page. The initial literature search across all databases and
organizational websites yielded 674 results. After the initial literature search, the titles of 516
results were skimmed for relevance. This included all results found in CINAHL, TRIP, JBI,
PsycINFO, ACOG, and AWHONN and only 160 results from the MEDLINE search. The first 160
results from MEDLINE were skimmed and after results no longer seemed relevant, 158 results
were eliminated without review. After skimming the titles of 516 results, 414 results were
eliminated because they were not relevant to the topic. This left 102 results to be screened for
use in the project by reviewing the abstracts. After screening and review, 71 pieces of evidence
were eliminated, 5 duplicate records identified were removed, and 26 pieces of evidence were
assessed for eligibility for use in this project. The 26 pieces of evidence were thoroughly
reviewed and assessed. Inclusion and exclusion criteria were applied to each article and 12
pieces were eliminated that did not meet these criteria, leaving 14 pieces of evidence for
consideration. After thoroughly reading and leveling the evidence, three more pieces of
evidence were eliminated that were lower levels of evidence and poor quality. The final number
of studies chosen for this project was 11 pieces of evidence. Refer to Figure 2.2, the PRISMA
flow chart, on the following page to follow each step of the literature search and review.
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Figure 2.2
PRISMA Flow Chart

Screening

Identification

Identification of studies via databases and registers

Records identified from:
CINAHL (n = 81)
MEDLINE (n = 318)
TRIP (n = 66)
JBI (n = 38)
PsycINFO (n = 112)
ACOG (n = 34)
AWHONN (n = 25)

Records removed before
skimming/screening:
Records removed for other
reasons (n = 158)

Records skimmed
(n = 516)

Records excluded
(n = 414)

Reports screened
(n = 102)

Reports not retrieved
(n = 71)
Duplicate records removed
(n = 5)

Reports assessed for eligibility
(n = 26)

Reports excluded:
Did not meet
inclusion/exclusion
criteria (n = 12)

Included

Lower levels of evidence
excluded (n = 3)
Studies included in review
(n = 26 )
Reports of included studies
(n = 11)
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Levels of Evidence
The resource used to level the evidence was the Melnyk and Fineout-Overholt leveling
system (Melnyk & Fineout-Overholt, 2019). Melnyk and Fineout-Overholt (2019) have a rating
system for the hierarchy of evidence and this system is used when an intervention or treatment
question is being considered. The levels of evidence are rated from level one to level seven,
with level one being the strongest level of evidence (Melnyk & Fineout-Overholt, 2019). There
are seven pieces of evidence being used for this project that are level I and four pieces of
evidence are level VII, according to Melnyk and Fineout-Overholt (2019). The level I pieces of
evidence include systematic reviews, evidence summaries, and CPGs. The four pieces of
evidence that fall into level VII include expert opinions that provide recommendations for
perinatal depression screening, intervention, referral, and follow up from accredited
organizations. Refer to Table 2.1 for a summary of the evidence, including leveling and quality
of evidence and tools used for appraisal.
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Table 2.1
Summary of Evidence

Author/yr

Database(s)

Level of
Evidence/Type

Quality/Tool

ACOG (2018)

TRIP

VII/Expert Opinion

High/JBI

Austin & Highet (2017)

TRIP

I/CPG

High/AGREEII

Che Abdullah et al. (2019)

TRIP

I/Systematic Review

High/CASP

Edwards MPhil (2020)

JBI

I/Evidence Summary

High/CASP

Kendig et al. (2017)

AWHONN

VII/Expert Opinion

High/JBI

Kurtz et al. (2017)

CINAHL

VII/Expert Opinion

Good/CASP

Learman (2018)

MEDLINE

VII/Expert Opinion

Good/CASP

Maurer et al. (2018)

CINAHL

I/Evidence Review

Good/CASP

O’Connor et al. (2016)

TRIP

I/Systematic Review

High/CASP

Registered Nurses’
Association of Ontario
(2018)

TRIP

I/CPG

Good/AGREEII

Simas et al. (2018)

MEDLINE

I/Systematic Review

Good/CASP
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Analysis and Appraisal of Relevant Evidence
Each piece of evidence was critically appraised using individualized appraisal tools to
determine the quality of evidence. Evidence summaries and systematic reviews chosen for this
synthesis paper were critically appraised using the Critical Appraisal Skills Programme (CASP)
appraisal checklists. The CASP appraisal tool provides checklists specific to the type of
evidence needing appraisal. These checklists are piloted with health care practitioners and
include questions to successfully appraise a systematic review. The expert opinions chosen
were critically appraised using the JBI appraisal tool. The JBI appraisal tool was chosen
because there is a checklist specific to expert opinions within this tool. The JBI appraisal tool for
expert opinions assesses the quality of the opinions and recommendations and ensures that the
opinion has standing in the field of expertise. The CPGs were critically appraised using the
Appraisal of Guidelines for Research and Evaluation (AGREE) II appraisal tool. The AGREE II
appraisal tool was chosen to critically appraise the CPG used in this paper because this tool is
specific to the appraisal of CPGs. The AGREE II assesses the quality of the guidelines and the
methods/strategies used to develop them. Health care providers can use this tool to assess
guidelines before implementing them into their practice.
Studies selected for synthesis were deemed as good or high-quality evidence after
appraisal. Each piece of evidence addressed a clearly focused question and identified the
population being studied (postpartum women). Studies reviewed in systematic reviews and
evidence summaries were of appropriate design and were assessed for quality by the authors
using appropriate appraisal tools and checklists. Evidence summaries provided best practice
recommendations for psychosocial assessment of women in the postpartum period based on
guidelines and systematic reviews included in the literature. The systematic reviews and
evidence summaries consisted of level I and level II evidence, including systematic reviews,
CPGs, and randomized control trials (RCTs) (Melnyk & Fineout-Overholt, 2019). The expert
opinions have a clearly identifiable and credible source and have a central focus on the topic at
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hand. Results from each article were similar, identifying the same screening tool used for
assessment of postpartum depression and similar schedules for postpartum follow up, which will
be discussed in the synthesis of evidence. Follow up care and interventions were also similar
amongst all evidence. Most importantly, findings from the evidence can be applied to the local
population and for use in the FNPs practice. Studies focus on the care of women in the perinatal
period, in a women’s health or primary care setting. Plans of care that are discussed are also
feasible and easily accessible.
Construction of Evidence-based Practice
Synthesis of Critically Appraised Literature
Screening tools for detection of postpartum depression.
A major trend found in the evidence was the use of screening tools for detection of
postpartum depression amongst women (ACOG, 2018; Austin & Highet, 2017; Che Abdullah,
2019; Edwards MPhil, 2020; Kendig et al., 2017; Kurtz et al., 2017; Learman, 2018; Maurer et
al., 2018; Moore Simas et al., 2018; O’Connor et al., 2016; RNAO, 2018). Consistent screening
with a validated tool is extremely important for detection and management of postpartum
depression (Kendig et al., 2017). Each piece of evidence mentioned the utilization of screening
tools used for the detection of postpartum depression, specifically the EPDS. The EPDS was
the most widely used tool for the assessment of postpartum depression in women amongst
most of the evidence chosen for synthesis (ACOG, 2018; Austin & Highet, 2017; Che Abdullah,
2019; Edwards MPhil, 2020; Learman, 2018; Maurer et al., 2018; O’Connor et al., 2016). The
EPDS was the most frequently used screening tool for screening for postpartum depression for
several reasons. The tool is translated into 50 different languages, includes only 10 selfreported questions that are health literacy appropriate, takes less than five minutes to complete,
and is a highly sensitive, valid tool (ACOG, 2018; Austin & Highet, 2017; Kendig, 2017; Kurtz,
2017; Maurer et al., 2018).
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Another screening tool frequently identified in the evidence for postpartum depression
screening was the Patient Health Questionnaire-9 (PHQ-9) (ACOG, 2018; Austin & Highet,
2017; Che Abdullah, 2019; Edwards MPhil, 2020; Kendig et al., 2017; Kurtz et al., 2017;
Learman, 2018; Maurer et al., 2018; O’Connor et al., 2016; RNAO, 2018). The PHQ-9 is also
recommended for screening for postpartum depression because it is only 9 questions, is easily
accessible, and has been validated in the perinatal population (ACOG, 2018; Che Abdullah,
2019; Kendig et al., 2017; Kurtz et al., 2017; Learman, 2018). However, the EPDS has been
found to be more adequate at diagnosing postpartum depression than the PHQ-9 (Maurer et al.,
2018).
The sensitivity and specificity of screening tools were discussed in the evidence to
determine accuracy of tools for screening of postpartum depression (ACOG, 2018; Austin &
Highet, 2017; Che Abdullah, 2019; Kendig et al. 2017; Kurtz et al., 2017; Learman, 2018;
Maurer et al., 2018; O’Connor et al., 2016). According to Che Abdullah et al. (2019), the EPDS
and Beck Depression Inventory (BDI) have the highest sensitivity out of the screening tools
assessed with both having a sensitivity of greater than 80%, indicating high accuracy. ACOG
(2018), Austin & Highet (2017), Kendig et al. (2017), Learman (2018), and O’Connor et al.
(2016) also report sensitivity for the EPDS ranging from 59% to 100% and specificity ranging
from 49% to 100%, depending on cutoff scores. Maurer et al. (2018) reports sensitivities and
specificities of 80% to 90% for the EPDS. Overall, evidence shows that the use of a screening
tool alone can have clinical benefits and early detection (through the use of screening tools) and
management of postpartum depression can prevent possible harmful effects (ACOG, 2018).
These harmful effects can include impaired growth and development of the newborn (Kurtz et
al., 2017), increased risk of poor adherence to health care, poor nutrition, loss of financial
resources, substance abuse, thoughts of suicide, and suicide (Kendig et al., 2017).
Timing for screening and assessment. Evidence shows that screening for postpartum
depression with a validated tool should occur at least once during the postpartum period
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(ACOG, 2018; Austin & Highet, 2017; Che Abdullah, 2019; Edwards MPhil, 2020; Kendig et al.,
2017; Kurtz et al., 2017; Learman, 2018; Maurer et al., 2018; Moore Simas et al., 2018;
O’Connor et al., 2016; RNAO, 2018). The postpartum period can be defined as the first 12
months following delivery (ACOG, 2018). According to Austin & Highet (2017), Learman (2018),
Maurer et al. (2018), O’Connor et al. (2016), and RNAO (2018), screening postnatally should
occur three to eight weeks after birth in the obstetric setting. Kurtz et al. (2017) recommends
screening for postpartum depression at two weeks, two months, six months, and 12 months.
The remainder of the evidence does not provide specific timing for screening but suggests
screening at least once in the postpartum period (ACOG, 2018; Che Abdullah, 2019; Edwards
MPhil, 2020; Kendig et al., 2017; Moore Simas et al., 2018). Evidence suggests waiting at least
two weeks postpartum to screen for depression considering the symptoms of “postpartum
blues” can last up to two weeks and can mimic symptoms of depression (Learman, 2018).
Follow up care for postpartum depression. The evidence also addressed different
follow up practices for postpartum women following screening for depression. Austin & Highet
(2017), Edwards MPhil (2020), Kurtz et al. (2017), and Learman (2018) recommend certain
follow up practices based on screening scores. Cutoff scores for positive screenings differed
amongst the screening tools and studies. Austin & Highet (2017) and Edwards MPhil (2020)
recommend monitoring a patient with a score of 10-12 on the EPDS and repeating the
screening in two to four weeks; specific ways to monitor these patients was not described. For a
patient with a score of 10 or more, Kurtz et al. (2017) recommends further evaluation, timing of
further evaluation was not specified, and planning an intervention or treatment plan, including
frequent follow ups, ensuring adequate support systems, and referral to mental health
professionals when necessary. According to Learman (2018), a cutoff score of 10 or greater and
12 or greater are the most commonly used threshold scores that indicate a positive screening.
Following a positive screening, Learman (2018) also suggests further assessment of symptoms,
addressing safety risks, screening for symptoms of mania and psychosis, and evaluating the
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patient for conditions that can form depressive symptoms. In a universal screening program
evaluated by Learman (2018), the obstetric care provider screened patients with a screening
tool and treated women who screened positive. Referral to a mental health specialist was only
done when clinically indicated, after assessment and diagnosis of postpartum depression
(Learman, 2018). Edwards MPhil (2020) states that a one-time score of 13 or 14 in the
postpartum period requires the primary care provider offer referral to an appropriate health
professional, such as an OB/GYN or mental health care provider. The health care professional
should ensure timely assessment and management by a mental health professional with a
score of 15 or greater on the EPDS (Edwards MPhil, 2020).
Furthermore, Austin & Highet (2017) and Kurtz et al. (2017) recommend immediate
intervention, based on local protocol/policy, with a positive response to question 10 on the
EPDS regarding suicidal ideation. Austin & Highet (2017) and RNAO (2018) go into further
detail on assessing the risk of suicide, including asking about suicidal thoughts and whether the
patient has a detailed plan, such as a method and a means for that plan. The health care
provider should also refer the patient for an urgent mental health assessment and consider
support and treatment options, including a safety plan (Austin & Highet, 2017; RNAO, 2018).
This safety plan should incorporate coping strategies, warning signs of imminent suicide,
support persons in the woman’s life, resources for health professionals and agencies that can
be contacted for help (Austin & Highet, 2017; RNAO, 2018). Kurtz et al. (2017) also suggests
activation of local emergency services or notification of child welfare agencies for women who
are suicidal or thinking about harming their infant. Kendig et al. (2017) recommends having an
emergency referral protocol in place for suicidal and homicidal ideation that includes emergency
psychiatric consult and collaboration of care between the health care provider and psychiatrist
(Kendig et al., 2017).
Follow up recommendations and practices differed in the remaining studies (ACOG,
2018; Kendig et al., 2017; Maurer et al., 2018; O’Connor et al., 2016; RNAO, 2018; Simas et al.,
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2018). ACOG (2018), Kendig et al. (2017), RNAO (2018), and Simas et al. (2018) recommend
coordination of care or referral to a mental health care professional for maximum benefit for
women who screen positive for postpartum depression. A positive screening is based on the
tool used and a cutoff value, which varies based on the clinic or provider (Kendig et al., 2017;
RNAO, 2018). The health care professional in the OB/GYN setting should be prepared to initiate
medical treatment and refer patients to appropriate behavioral health resources, or both (ACOG,
2018). Kendig et al. (2017) suggests development of a management algorithm for positive
screening results by the maternity health care provider to facilitate appropriate interventions and
referrals. Interventions include support from family and friends, psychotherapy, such as
cognitive behavioral therapy (CBT), and strong consideration of initiating a selective serotonin
reuptake inhibitor (SSRI) or a serotonin-norepinephrine reuptake inhibitor (SNRI) (Kendig et al.,
2017). These interventions can be provided in the OB/GYN setting or in coordination with a
mental health care provider (Kendig et al., 2017)
Pharmacologic and alternative treatment for postpartum depression. Following a
positive screening and diagnosis of postpartum depression, pharmacologic and alternative
treatment should be considered (ACOG, 2018; Austin & Highet, 2017; Kendig et al., 2017;
O’Connor et al., 2016; RNAO, 2018). For women with moderate to severe postpartum
depression, alternative treatment should be considered in addition to pharmacologic treatment,
including CBT, exercise, time for self, and support from peers and family (Austin & Highet, 2017;
Kendig et al., 2017; O’Connor et al., 2016; RNAO, 2018). First line pharmacologic treatment for
moderate to severe postpartum depression is an SSRI (Austin & Highet, 2017; Kendig et al.,
2017). There is high quality evidence to support the efficacy of SSRI antidepressants for
treatment of postpartum depression and exposure to SSRIs through breast milk is very low
(Austin & Highet, 2017). However, the potential risks of antidepressants should be discussed
with the patient before initiation of medication (Austin & Highet, 2017; Kendig et al., 2017;
O’Connor et al., 2016; RNAO, 2018).
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SSRIs approved by the Food and Drug Administration (FDA) include citalopram,
escitalopram, fluoxetine, paroxetine, and sertraline. According to Hale (2021), sertraline and
escitalopram are preferred over other SSRIs for pregnant and breastfeeding women.
Escitalopram and sertraline have been shown to be effective in treating postpartum depression
and transfer of these medications through breastmilk is minimal (Hale, 2021). A suggested dose
for escitalopram is 10 to 20 milligrams daily and a suggested dose for sertraline is 50 to 200
milligrams daily. Side effects for women taking these medications include headaches, dizziness,
insomnia, diarrhea, and nausea (Hale, 2021). In a study on the use of escitalopram, no adverse
events were reported in infants when their mothers were taking this medication while
breastfeeding (Hale, 2021). Possible side effects of sertraline in an infant include sedation,
irritability, not waking to feed or poor feedings, and weight gain (Hale, 2021).
Recommendation for Best Practice
Based on the evidence, the best practice to address the clinical problem was the use of
the EPDS screening tool to detect postpartum depression (ACOG, 2018; Austin & Highet, 2017;
Che Abdullah, 2019; Edwards MPhil, 2020; Learman, 2018; Maurer et al., 2018; O’Connor et
al., 2016). The screening tool should be administered at the 2- or 6-week postpartum visit and
reassessment and follow up will be based on initial screening scores (Austin & Highet, 2017;
Learman, 2018; Maurer et al., 2018; and O’Connor et al., 2016). Screening should be done at
the 2- or 6-week postpartum visit for convenience, considering most women are seen 2- to 6weeks after delivery. A cutoff score of 10 or greater will be used for further assessment (Austin
& Highet, 2017; Edwards MPhil, 2020; Kurtz et al., 2017; and Learman, 2018).
A treatment plan should be discussed for women who have a score of 10 or greater and
the patient should be rescreened with the EPDS in 2 to 4-weeks (Austin & Highet, 2017;
Edwards MPhil, 2020). This treatment plan should include appropriate support systems,
resources, and the possibility of pharmacologic treatment, if deemed necessary by the patient
and health care provider (Women’s Health Nurse Practitioner or OB/GYN) (ACOG, 2018; Austin
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& Highet, 2017; Edwards MPhil, 2020; Kendig et al., 2017; Learman, 2018; Moore Simas et al.,
2018; O’Connor et al., 2016; RNAO, 2018). Pharmacologic treatment should include an SSRI
for treatment of postpartum depression (Austin & Highet, 2017; Hale, 2021; Kendig et al., 2017).
If the EPDS score remains high with the second screening, a change in treatment may need to
be made, including strong recommendation for referral to a mental health care provider (ACOG,
2018; Kendig et al., 2017; Moore Simas et al., 2018; RNAO, 2018). A protocol should be put in
place at the clinic to ensure initiation of the above recommendations for best practice.
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CHAPTER 3
IMPLEMENTATION OF PRACTICE CHANGE
The implementation of the practice change took place in an obstetrical/women’s health
care setting in Munster, Indiana. Key stakeholders were involved in each step of the practice
change. These key stakeholders included RNs at the clinic, the OB/GYN, the nurse practitioner,
and the DNP student. The practice change included a protocol for screening all women at 2- or
6-weeks postpartum that described, in detail, the steps for implementation of the practice
change. Refer to appendix C for the protocol. All participants signed a project consent form,
completed a demographic form, and received a patient education handout with information on
how to detect and manage symptoms of postpartum depression at the beginning of their 2- or 6week postpartum visit. Refer to appendix A for the patient education handout. The receptionists
administered the EPDS in paper format to all postpartum women at their 2- or 6-week
postpartum checkup for both post-cesarean section and post-vaginal delivery patients. The
RN’s entered the paper form into each patient’s chart electronically. Results of the screening
were interpreted by the OB/GYN physician who referred to the protocol for screening and
appropriate follow up and treatment. The protocol included guidance on when to screen, who to
screen, and information on the EPDS tool. A cutoff score, timing for follow up, referral
recommendations, pharmacologic and alternative treatment, guidance on suicide assessment,
and emergency services information were also included in the protocol. The protocol stated that
administration with a paper form of the EPDS will be done by the receptionist and results of
screening will be entered into the patient’s chart by the RN. The results of the screening were
reviewed by the provider with the patient and follow up and treatment were determined. Follow
up for a positive screening was scheduled for four weeks after the initial screening and the
provider encouraged those with a positive screening to engage in alternative therapies, as
discussed in the patient education handout. Treatment options following a positive screening
and diagnosis of postpartum depression included prescription by the physician of an SSRI,
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referral to a behavioral health clinic or mental health care provider, referral for CBT, education
on exercise regimens, advice on how to create time for self, and ensuring the patient has
support from others. The protocol also included how to assess for women who are at risk for
suicidal and/or homicidal ideation. This assessment included inquiring about feelings of
suicidal/homicidal ideation, assessing whether or not the patient responded yes to question 10
on the EPDS, and assessing patient and infant safety and the patient’s support system. For
women who are at high risk of suicide, as explained in the protocol, the provider would arrange
for an emergency psychiatric consult or contact 911 for transfer to a nearby emergency
department or psychiatric unit.
Participants and Setting
The participants taking part in this practice change included key stakeholders and
patient participants at the clinic. Key stakeholders included RNs at the clinic, an OB/GYN
physician, a nurse practitioner, and patients at the clinic. The OB/GYN physician has been in
practice for 22 years, specializing in obstetrics and gynecology. The nurse practitioner is a
family nurse practitioner (FNP) and has been in practice for six years. Patients taking part in the
practice change included women of all ages and ethnicities who were at least 2 weeks into the
postpartum period following birth. Those who were ineligible included pregnant women and
women who were not in the postpartum period.
The clinic was an obstetrics and gynecology women’s health clinic with one physician
and one nurse practitioner, as well as RNs and secretarial staff. The area in which the clinic was
located, Munster, Indiana, had an estimated population of 22,476 with 50% of the population
being female persons (United States Census Bureau, 2019). The nurse practitioner conducted
about 48 patient visits a week, and the physician conducted about 80 patient visits a week (K.
Castillo, personal communication, July 28, 2021), which amounts to about 500 patients a month
or 6,000 patients a year. In 2011, 15,794 United States physicians specializing in obstetrics and
gynecology were surveyed for a compensation report that found about 50% of these physicians
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saw 50-99 patients a week. Considering these data, the clinic where the project took place is on
average with other clinics in the US regarding the number of patients seen per week.
Pre-Intervention Group Characteristics
Demographic information was collected on patients seen in the clinic for a 2- or 6-week
postpartum visit prior to initiation of the project from February 23rd, 2021, to July 7th, 2021. Of
the 39 patient charts reviewed, 10 patients were of African American race, 15 patients were
Caucasian, one patient was Asian and African American, 10 patients were of Hispanic ethnicity,
and three patients did not have a race or ethnicity listed. Ages of patients ranged from 19 years
old to 44 years old. One patient from the original chart audit was diagnosed and treated for
postpartum depression, a 20-year-old African American female. Patient demographics were
collected on project participants during implementation and findings were compared with preintervention data.
Intervention
To prepare and plan for the intervention, several steps were implemented. A detailed
protocol was made to identify patients with postpartum depression and provide appropriate
follow up care. Key stakeholders were educated about the project and intervention. Provider
education included in the protocol took place prior to the implementation phase of the project. A
provider education handout was made available to staff in addition to a group, one-hour inperson education session provided by the project leader. The education included how to
administer and interpret results of the EPDS. Appropriate timing for follow up and treatment was
discussed for women screened positive and were diagnosed with postpartum depression.
Specific treatment options including prescription of an SSRI and resources for alternative
treatment were discussed with the providers. Education about how to assess for risk of suicide
and the steps to follow for women at risk was provided. While the RNs, physician, and nurse
practitioner at the clinic were familiar with the screening tool being utilized, an overview of the
EPDS was provided prior to implementation. Paper copies of the EPDS were made and on
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hand at the clinic for the receptionists to administer. The RNs also received an overview on
where and how to enter each patient’s EPDS score into their chart. This information was also
included in the protocol in more detail, which was readily available to staff and providers. Refer
to appendix B for the provider education handout.
The practice change involved administration of the EPDS to all women at their 2- or 6week postpartum checkup. A paper form of the EPDS was completed by each participant and
results were entered into their chart by the RN. The physician then interpreted results and
discussed them with the participant. A cutoff score of 10 was used for a positive screening for
postpartum depression. For participants with a score of 10 or greater on the EPDS, the provider
determined a diagnosis of postpartum depression, based on symptoms and clinical judgement.
A 4-week follow up visit was scheduled for any participant with a positive screening (a score of
10 or greater) who was not diagnosed with postpartum depression, and reassessment of the
participant took place. Pharmacologic and alternative treatment were discussed at the 2- or 6week postpartum visit with the participant if they screened positive and were diagnosed with
postpartum depression. If the provider and the participant decided on pharmacologic treatment,
the provider was to prescribe an SSRI. SSRIs that are recommended most often for treatment
of postpartum depression include sertraline and escitalopram (Hale, 2021) because they have
less reported side effects and transfer of these medications through breastmilk is minimal (Hale,
2021). Alternative treatment options discussed with the participant included CBT, exercise, time
for self, and support from peers and family (Austin & Highet, 2017; Kendig et al., 2017;
O’Connor et al., 2016; RNAO, 2018). The participant who was diagnosed with postpartum
depression was scheduled to follow up with the provider in two weeks. A handout was given to
participants with specific interventions for exercise, time for self, and support from peers and
resources for where to receive CBT as part of alternative treatment. The number for the
National Suicide Prevention Lifeline and education on what to do when having suicidal thoughts
was also included in the handout as well. For a participant with a positive answer to question
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number 10 on the EPDS, the provider was to arrange for an urgent mental health assessment
with a mental health care provider and activate the local emergency services, if necessary,
based on the participant’s risk of suicide (Austin & Highet, 2017; Kendig et al., 2017; Kurtz et al.,
2017; RNAO, 2018). If a participant was at high risk of suicide, activation of local emergency
services included calling 911 for transfer to the emergency department. A list of mental health
care providers in the area were readily available for the providers to refer to as well as a list of
nearby emergency departments if activation of local emergency services was warranted.
Comparison
Current practice in the clinic for screening of postpartum depression did not follow
evidence-based research and practice. Screening for postpartum depression was done by the
physician and this included asking questions at the postpartum visit, rather than screening with
a validated tool as suggested in the evidence. An audit of electronic medical record (EMR)
charts done for a 4 ½ month period from February 23rd, 2021, to July 7th, 2021 found that 2.5%
of patients seen for their 2- or 6-week postpartum visit by the physician at the clinic were
screened with the EPDS after the patient reported depressive symptoms. The clinic did not have
a protocol or plan in place to follow when a patient screens positive for postpartum depression
or suicidal ideation.
Outcomes
The number of patients screened with the EPDS after implementation of the project was
evaluated as the primary outcome. The primary outcome was measured as a frequency. The
number of patients screened with the EPDS prior to implementation was assessed and
compared to the number of patients screened with the EPDS after implementation. A change in
the detection rate of postpartum depression within the clinic was evaluated as the secondary
outcome using the EPDS. Although the EPDS is a valid and reliable tool to screen for and
detect postpartum depression (Che Abdullah, 2019), it was not used alone to diagnose
postpartum depression. Patient symptoms and the provider’s clinical judgment, along with a
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positive screening with the EPDS, constituted a diagnosis. To ensure providers were
knowledgeable about screening and diagnosing a patient with postpartum depression,
education was provided on specific risk factors and symptoms that are consistent with a
diagnosis of postpartum depression. Participant demographics were collected by having each
participant fill out a demographics form. A code sheet was created with participant names and a
code number assigned to each. This code number was used on the paper EPDS form and the
demographic form to link the data collected from these two forms. A chi-square test was used to
determine if there was a significant difference in screening and detection of postpartum
depression after implementation of the project.
Time
Project implementation began after the start of the Fall semester, in mid-September.
Provider and staff education took place on September 30th, 2021, one week prior to
implementation. The in-person education session held by the project leader was done in a
group setting, including all staff and providers, and took about one hour. Implementation of the
project was projected to take place for 12 weeks. However, to recruit more participants, the
implementation phase and data collection took 19 weeks.
Protection of Human Subjects
Research ethics training was completed prior to the start of this EBP project through the
Collaborative Institutional Training Initiative program. To maintain participant anonymity and
confidentiality, each participant was assigned a code number and the DNP student was the only
person with access to the code sheet. The code sheet with participant names and code
numbers did not leave the clinical site and was kept in a locked file cabinet in the providers’
office. Code numbers were placed on each participant’s paper EPDS form and demographic
sheet to link the participant’s EPDS to their demographics.
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CHAPTER 4
FINDINGS
The purpose of this EBP project was to improve screening and management of
postpartum depression using the EPDS screening tool and a protocol for appropriate treatment
and follow up care. The number of participants screened with the EPDS comprised the primary
outcome and was measured as a frequency. The secondary outcome of detection rates of
postpartum depression was measured by EPDS scores of 10 or greater. Additionally, the impact
of demographic variables on EPDS scores was measured as another secondary outcome.
Statistically significant differences were found between the preintervention and postintervention
groups for the primary outcome of the project. The secondary outcome of detection rates of
postpartum depression was not statistically significant between the preintervention and
postintervention groups. The secondary outcome of impact of demographic variables on EPDS
scores was statistically significant for the variable of age between the preintervention and
postintervention groups.
Participants
The postintervention group that participated in the EBP project consisted of postpartum
women of varying races and ethnicities, ages 18 to 44. The preintervention and postintervention
groups had similar demographic characteristics and the postintervention group was reflective of
the entire patient population. An independent t-test determined there was no statistically
significant different in age (p = .793) between the preintervention and postintervention groups. A
chi-square test determined there was no statistically significant difference in race (p = .112)
between the preintervention and postintervention groups. The population of women in both
groups was racially diverse, representing the entire population. Races and ethnicities identified
amongst both groups include African American, White, Hispanic, and Asian. Of the women in
the preintervention group, 28% were African American, 38% were White, 26% were Hispanic,
and 8% did not have a race or ethnicity listed. Of the women in the postintervention group, 22%
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were African American, 46% were White, 2% were Asian, and 30% were Hispanic. These
percentages show similarities of races amongst the two groups. A chart audit was done on 39
postpartum women for data collection, or the preintervention group, and the postintervention
group comprised of 18 postpartum women who participated in project implementation. Of the 34
women who were seen for a postpartum visit during the implementation phase, 18 of them
participated. One provider, a nurse practitioner, did not participate because she did not have
any postpartum visits during project implementation. Refer to table 4.1 for demographic
characteristics of the preintervention and postintervention groups. Refer to appendix F for the
patient demographic form completed by all project participants.

29

Table 4.1
Demographic Characteristics

Characteristic

Age (mean)

Postintervention Group

Preintervention Group

Total

n = 18

n = 39

N = 57

30.4

29.9

30.1

Race

t

X2

-.264

.793
6.000

African American

22%

26%

White

46%

38%

Asian

2%

0%

Hispanic

30%

26%

Other

0%

2%

None listed

0%

8%

Education Level
High school

22%

p

.112
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Some college

22%

College Degree

56%

Job Status
Full time

50%

Part time

6%

Unemployed

44%

Marital Status
Married

67%

Single

33%

Social History
Alcohol use

6%

History depression

17%

None

78%
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Changes in Outcomes
Implementation of the EPDS screening tool made a statistically significant difference for
screening rates between the preintervention and postintervention groups. Data analysis of the
secondary outcome of detection rates of postpartum depression was not able to be ran because
of the small sample size. The effect of demographic variables on EPDS scores was also
analyzed as a secondary outcome. The variable of age significantly affected EPDS scores. The
variables of race, job status, marital status, education level, and social history did not affect
EPDS scores.
Statistical Testing and Significance
Data were analyzed using the Mann-Whitney test, chi-square test of independence, and
a simple linear regression to determine if there was a significant increase in screening rates of
postpartum depression between the preintervention and postintervention groups and if
demographic variables affected EPDS scores. The chi-square test of independence was an
appropriate statistical test for examining nominal variables of race, job status, marital status,
and social history because there were two independent groups, and the outcomes were
measured as frequencies (Cronk, 2018). The Mann-Whitney test was an appropriate statistical
test for examining ordinal variables of age and education level because there were two
independent groups (Cronk, 2018). A simple linear regression was used to determine if
demographic variables had an impact on final EPDS scores and this was an appropriate test to
allow prediction of one variable from another variable (Cronk, 2018).
Findings
Primary Outcome
Screening Rates with EPDS. Screening rates for postpartum depression using the
EPDS tool increased significantly in the postintervention group compared to the preintervention
group. Prior to project implementation, 2.6% of patients (1 out of 39) seen for a postpartum visit
were screened with the EPDS tool. During the implementation phase, 52.9% of patients (18 out
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of 34) seen for a postpartum visit were screened with the EPDS tool. There was a 50.3%
increase in screening rates using the EPDS as a result of this EBP project.
Secondary Outcome
Detection Rates of Postpartum Depression. Data analysis on the secondary outcome
of detection rates of postpartum depression was not possible due to the small number of
participants diagnosed with postpartum depression in the preintervention and postintervention
groups. However, only one patient seen for a postpartum visit in the preintervention group was
diagnosed with postpartum depression as opposed to two participants in the postintervention
group as a result of using the EPDS tool. Therefore, there was a 100% increase in detection
rates of postpartum depression as a result of project implementation.
Demographic Variables and EPDS Scores. When analyzing demographic variables to
determine if there was a statistically significant difference between participants who had an
EPDS score of less than 10 versus those who had an EPDS score of greater than 10, the
variable of age was statistically significant (p = .048). The variable of education level was not
statistically significant (p = .639). These data were analyzed using the Mann-Whitney Test.
When determining if demographic variables impacted the final EPDS scores, the variable of age
was statistically significant (p = .044), affecting the final EPDS score. The variables of education
level, job status, race, marital status, and social history were not statistically significant. These
data were analyzed using a linear regression. After using backward regression to look at
demographic variables and their effect on final EPDS scores, the variables of age (p = .005) and
education level (p = .037) were both statistically significant and are the best predictors of EPDS
scores. After further analyzing the data, women with the highest EPDS scores were in their
middle 30s and had at least a high school level diploma.
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Figure 4.1
EPDS Screening Rates
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CHAPTER 5
DISCUSSION
This EBP project was implemented to improve screening and management of
postpartum depression using the EPDS screening tool and a protocol for appropriate treatment
and follow up care. Demographic variables were collected on project participants and the EPDS
tool was administered to properly screen for postpartum depression at 2- or 6-week postpartum
visits. A data analysis was performed to determine if there was a difference in screening and
detection rates of postpartum depression using the EPDS between the preintervention and
postintervention groups, and if demographic variables affected EPDS scores of participants in
the postintervention group. Findings from this EBP project and how they are linked to the role of
the doctorally prepared nurse will be discussed.
Explanation of Findings
Primary Outcome
There was a significant change in screening rates using the EPDS between the
preintervention and postintervention groups. Amongst the women who were seen for a
postpartum visit during the implementation phase of the project, 52.9% of women were
screened with the EPDS and were participants in this EBP project. A chart audit of women seen
for a postpartum visit prior to implementation of this EBP project (preintervention group) reveals
only 2.6% of women seen for a postpartum visit were screened with the EPDS. Therefore, the
primary outcome to increase screening rates for postpartum depression was met by using the
EPDS and implementing this EBP project. According to the literature, assessing for postpartum
depression with an appropriate tool is crucial to properly screen for and detect postpartum
depression (ACOG, 2018; Austin & Highet, 2017; Che Abdullah, 2019; Kendig et al. 2017; Kurtz
et al., 2017; Learman, 2018; Maurer et al., 2018; O’Connor et al., 2016). Screening with a tool
such as the EPDS allows for early detection and management of postpartum depression to
prevent harmful effects of this common mood disorder (ACOG, 2018).
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Secondary Outcomes
Detection Rates of Postpartum Depression
Statistical testing was not possible to determine if there was a difference in detection
rates between the preintervention and postintervention groups due to the small number of
positive screenings in both groups. Prior to implementation, one woman in the preintervention
group was screened using the EPDS and postpartum depression was detected. During
implementation of this EBP project, postpartum depression was detected in two participants as
a result of screening with the EPDS. There was a 100% increase in detection rates of
postpartum depression after implementation of this EBP project, assuming the EPDS had an
impact on detection rates of postpartum depression amongst this group of women. According to
the literature, the EPDS is a highly accurate and reliable tool to detect postpartum depression
early (ACOG, 2018; Austin & Highet, 2017; Che Abdullah, 2019; Kendig et al. 2017; Kurtz et al.,
2017; Learman, 2018; Maurer et al., 2018; O’Connor et al., 2016).
The physician followed the protocol to educate participants who had positive screenings
(EPDS score of 10 or greater) about follow up screening and how to manage these symptoms
at home or with treatment. The physician further discussed symptoms each participant was
experiencing, and they denied any thoughts of harming oneself or others. Both participants
declined treatment at that time. They were instructed to follow up in 4 weeks for repeat
screening with the EPDS and to discuss any symptoms they might be having at that time. Both
participants were also instructed to refer to the patient education handout they received for
information on how to manage symptoms of postpartum depression at home and call the clinic
with any questions or concerns prior to their follow up visit.
Demographic Variables and EPDS Scores
After analyzing the data, the variable of age had a statistically significant impact on
EPDS scores. The variable of age effects if the EPDS score will be greater than or less than 10,
with 10 or greater indicating a positive screening, and the overall EPDS score itself. After further
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analyzing the data, participants ages 18 to 33 had EPDS scores between 1 and 5 compared to
those in their middle 30s with the highest scores of 11 and 18. This suggests women in their mid
30s are at higher risk of postpartum depression. However, this may not be a valid or reliable
finding considering only two participants scored 10 or greater. These findings are not consistent
with the literature. According to the literature, risk factors for postpartum depression include a
personal and/or family history of depression, diagnosis of bipolar disorder, postpartum
depression with previous pregnancy, stressful life events, having a child with special needs,
having multiples, an inadequate support system, financial problems, and an
unplanned/unwanted pregnancy (MFMER, 2018). Age and education level were not found to be
risk factors. If these findings were consistent with the literature, the variables of job status,
marital status, and social history would have significantly affected EPDS scores. The participant
with an EPDS score of 11 did have a history of depression and was not married, which are both
risk factors for postpartum depression. This finding was not statistically significant because only
two women had an EPDS score of 10 or greater.
Strengths and Limitations of the DNP Project
Strengths
A major strength of this EBP project was the increase in the use of the EPDS to screen
for postpartum depression between the preintervention and postintervention groups. There was
a 50.3% increase in screening rates using the EPDS after implementation of this EBP project.
The EPDS is a very simple and cost-effective way to screen for postpartum depression. This
screening tool takes minimal time to complete by the patient and is an effective way to detect
postpartum depression early and treat appropriately. The physician and staff at the women’s
health clinic also agree that the EPDS is a very efficient and easy way to screen for postpartum
depression.
Another strength of this project was the ease of recruiting participants. Recruitment and
screening of participants took place at the same time for those who consented to participate in
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the project. Participants were able to fill out the consent form, demographic form, and the EPDS
at the same time while waiting to see the provider. The patient education handout was also
given at this time for the participant to look over and take home for reference. This handout was
a great reference for participants to learn more about postpartum depression and when to
consult with their healthcare provider at a postpartum visit and/or in the future.
Providing a protocol to the healthcare providers at the women’s health clinic for
screening and follow up management for postpartum depression was also a strength of the
project. The protocol was a great way for providers to consistently screen for postpartum
depression and appropriately treat patients when necessary. Multiple evidence-based treatment
options were listed on the protocol for providers to follow, along with how to treat those with
suicidal ideation.
This EBP project was successful because of the dedication of the project site facilitator
and staff that recruited participants and administered the EPDS forms, which is also identified
as a major strength. The project site facilitator often encouraged or reminded staff to recruit
participants and staff made sure to comply. After being out of the office with COVID-19, the
receptionists made sure to get right back on track with implementation of the project upon their
return. The staff and project site facilitator were very cooperative with the extension of project
implementation to recruit more participants and worked hard until the end.
Limitations
Limitations were encountered throughout the implementation phase of this EBP project
and were addressed accordingly. Staff-related factors arose rather quickly during
implementation. The RN that was to administer the EPDS paper forms along with patient
consent and demographic forms was not cooperative with this process. She insinuated that she
did not have the time to administer these forms while also rooming patients for the physician
and nurse practitioner visits. To address this issue, the project leader spoke with the
receptionists at the front desk to discuss an easier route for administration of these forms. The
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receptionists were very open to changing the process of implementation and administering the
forms to patients. The receptionists explained project implementation to women being seen for a
postpartum visit and asked for their consent to participate in the project. After consent was
received, participants were given the EPDS form and demographic form to fill out prior to seeing
the physician. However, an unexpected confounding factor occurred with the receptionist staff.
During the Winter break, both receptionists contracted COVID-19 and were out of the office for
several weeks. Due to their absence, very few patients were recruited for participation in the
EBP project during this time. Unfortunately, there was no way to fully address this unexpected
confounding factor rather than to recruit as many participants as possible for the project after
the receptionists returned. Having to rely on staff to recruit participants for this project was also
a limitation for these reasons.
Sustainability
After implementing the project at the clinical site, the project leader had a conversation
with the physician and nurse practitioner at the site to ensure they were interested in sustaining
the project and they agreed. Outcomes of this EBP project were then shared with the staff at the
clinic to show the importance of implementing and sustaining this practice change. A meeting
was held between the project leader and the staff, including the physician and nurse
practitioner, to make sure staff would consistently administer the EPDS tool to all postpartum
women at their 2- or 6-week postpartum visit to sustain the new practice of this EBP project.
The staff were reminded of the ease and importance of screening with the EPDS. To maintain
this practice change without the presence of the project leader, the EPDS paper forms will
remain with the receptionists at the front desk in a folder directly next to the computers to
handout while checking the patient into the computer system. The patient will complete the
EPDS form while waiting to see the physician. The physician will then make sure postpartum
patients completed the EPDS form prior to starting their visit. The project leader also suggested
posting flyers in the clinic waiting room and on exam room doors, prompting postpartum women
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to ask about depression screening if they have not yet received the EPDS form. These
suggestions will help sustain this practice change. Refer to Appendix G for this flyer.
Relevance for EBP Model
The JHNEBP model was very useful for guiding this EBP project. The three-step
process of identifying a practice question, searching for evidence, and translating EBP into
practice was helpful for all stages of this project. The model also incorporates internal and
external factors to consider when implementing a practice change. These components of the
JHNEBP model were most helpful and aligned well with the project. Prior to implementation, the
project leader met with the project site facilitator to identify a needed practice change for the
clinical site and the project leader identified a practice question. After identifying a needed
practice change, the project leader did an extensive literature search and selected evidence
appropriate for the EBP project. The evidence was appraised and revealed evidence was of
good or high quality. Findings were then synthesized to create a protocol. Specific
recommendations for the practice change were identified and a plan for implementation of the
EBP project was determined. To guide project implementation, the translation step of the PET
process, best practices, and practice improvements were helpful components of the model. The
plan included translating evidence into practice at the clinical site to improve screening and
follow up management for postpartum depression. Best practices were identified in the evidence
and were utilized to create a plan for implementation and improve current practice at the
women’s health clinic.
After starting the implementation phase of the project, internal factors were considered
and identified throughout this phase, including issues with staffing and environmental factors. As
discussed previously, the RN that was to recruit participants and administer EPDS forms was
not cooperative with project implementation. This was an internal factor of staffing issues. The
environmental factor that influenced project implementation was COVID-19. Both receptionists
that were to recruit participants and administer EPDS forms were ill with COVID-19 during
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project implementation, which influenced the recruitment of participants. The project leader was
prepared for these internal factors and addressed the accordingly. It is evident the JHNEBP
model was useful throughout this EBP project.
External factors were also identified as a result of using the JHNEBP model as a guide.
The external factor of standards applies to this EBP project. Standards of care were not being
met at the clinical site prior to implementation of this project. This lack of standards was the
motivation for this EBP project. Standards of care are extremely important for practice. They are
the guidelines all healthcare providers must follow to ensure patient safety and quality care. As
a result of this EBP project, standards of care for screening and follow up for postpartum
depression were met and will continue to be met at this women’s health clinic by sustaining this
practice change.
Although several components of the JHNEBP model were helpful for this EBP project,
there were some parts to the model that were not useful. Because this EBP project was not a
research project, the research portion of the model was only helpful when searching for
evidence related to the practice change.
Recommendations for the Future
This EBP project provided consistent screening for postpartum depression, a protocol for
screening and management of postpartum depression, and patient and provider education.
Implications for the future regarding practice, research, and education will be discussed.
Research
Further research is necessary to further identify risk factors for postpartum depression.
Maternal age, race, and education level are potential characteristics that could affect EPDS
scores and increase risk for postpartum depression, along with employment/financial status,
support systems, and social history as already identified in the literature. Data analysis from this
EBP project determined that age and education level have a correlation with EPDS scores.
Although race did not affect EPDS scores in this EBP project, there is currently not enough
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literature to determine if race affects EPDS scores and risk for postpartum depression. Further
research is necessary to determine if maternal age, race, and education level affect EPDS
scores and risk for postpartum depression. To build knowledge on this intervention, research is
needed on the use of the EPDS in women’s health clinics specifically. The literature concluded
that postpartum depression screening should occur in settings such as primary care, obstetrics,
and pediatrics and the EPDS was the most common and valid tool for use (ACOG, 2018; Austin
& Highet, 2017; Che Abdullah, 2019; Edwards MPhil, 2020; Learman, 2018; Maurer et al., 2018;
O’Connor et al., 2016). However, limited evidence was found that focused on the use of the
EPDS in women’s health clinics.
Practice
Despite being years into the pandemic, this EBP project was greatly affected by COVID19. Recommendations for future practice and similar projects would be to conduct the project or
practice change when there would be less risk for challenges and restrictions due to the
pandemic. It is also recommended for future EBP projects and practice changes that the project
or practice change leader recruit participants for the project, rather than relying on staff for
recruitment. Recruitment of participants should be separated from project implementation. This
could be done by making phone calls ahead of time to women who are scheduled for a
postpartum visit to explain the EBP project and ask for consent to participate at their future visit.
To further improve positive outcomes of a practice change, it is recommended that the project
leader or practice change leader ensure staff are fully cooperative prior to implementing the
practice change at that clinical site.
Education
Considering this EBP project was successful in increasing screening rates using the
EPDS, the project site opted to continue the intervention. It is necessary to continue educating
the staff on the importance of this intervention to ensure they are compliant with giving all
postpartum patients the EPDS form prior to seeing the provider. The providers should also
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ensure staff are continuing the intervention by making sure with each postpartum patient that
they received and completed the EPDS form. Undergraduate and graduate nursing students
should be educated on the topic of postpartum depression, including how to screen for and treat
this condition. Undergraduate and graduate students should also be knowledgeable on how to
educate postpartum women about the risk factors and symptoms of postpartum depression and
what to do if experiencing symptoms.
Conclusion
The results of this EBP project determined that screening for postpartum depression with
the EPDS tool is feasible, cost-effective, and simple. Using this tool to screen for postpartum
depression allows for early detection and management of this mental health condition to prevent
potential harm to the mother and her family. Administering the EPDS form to postpartum
patients takes minimal effort from the staff and can be filled out by the patient in minutes. The
use of a detailed protocol assisted providers in the screening and management of postpartum
depression. The goal of this EBP project is to sustain the intervention of administering the EPDS
tool to 100% of postpartum patients at this women’s health clinic. It is recommended that all
postpartum women are screened with a valid and reliable tool, such as the EPDS, at their
postpartum visit.
In conclusion, the primary outcome to increase postpartum depression screening with
the EPDS was achieved. A 50.3% increase in EPDS screening rates was seen after
implementation of this EBP project. Achieving an EPDS screening rate of 100% would facilitate
early detection and treatment of postpartum depression. If left undetected and untreated,
postpartum depression can have devastating effects, including maternal death (ACOG, 2018;
Austin & Highet, 2017). Death from maternal suicide exceeds maternal death from postpartum
hemorrhage and hypertensive disorders (ACOG, 2018). Considering these statistics, it is
extremely important postpartum women are properly screened for depression with a valid and
reliable tool, such as the EPDS.
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APPENDIX A
Patient Education Handout

Understanding and Managing
Postpartum Depression



What is postpartum depression? Postpartum depression is a common mood disorder that can
occur up to 1 year after giving birth



What are symptoms of postpartum depression?
o Depressed mood and/or agitation
o Decreased pleasure/interest in activities
o Significant weight loss or weight gain
o Difficulty sleeping at night or sleeping too much at night/during the day
o Fatigue or decreased energy
o Feelings of hopelessness or worthlessness
o Recurring thoughts of death or suicide



How can you manage postpartum depression at home?
o Exercise
 Walking, yoga, light weight training, bicycle rides, swimming once bleeding has
stopped
o Time for self
 Ask for help from partner/family/friends
 Write in a journal
 Read a book
 Rest when the baby is napping/sleeping
o Support from peers
 Talk to and spend time with family and friends, seek help or advice from peers
What are suicidal thoughts/being suicidal?
o Recurrent thoughts of death or harming yourself
o Thinking about a plan to carry out the act of suicide
o Having the means to carry out the act of suicide (gun, pills, etc.)
What to do when you are having suicidal thoughts
o Tell your doctor/nurse practitioner if you are at the office
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o
o

Call the National Suicide Prevention Lifeline number: 1-800-273-8255 or text the Crisis
Text Line by texting HELLO to 741741
If you plan to attempt suicide, call 911 immediately
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APPENDIX B
Provider Education Handout

Postpartum Depression:
Screening, Treatment, and Follow Up




DNP project will begin 9/20/2021 with plans to end 12/13/2021, however standard of care will
continue with screening with the EPDS
Screening will be done at 2 or 6-week postpartum visit for all women using the EPDS
o A paper form of the EPDS should be completed only by the patient by checking off the
response that comes closest to how she is feeling
o The EPDS scores from each question should be added and a final score should be
calculated by the physician or NP
o EPDS results should be entered into each patient chart



Diagnosis of postpartum depression will be made based on the provider’s clinical judgment,
patient symptoms, and an EPDS score of 10 or greater
o DSM-5 criteria for depressive disorder
 5 or more of the follow symptoms present during 2 consecutive weeks
 Depressed mood most of the day, nearly every day; markedly decreased
interest in all or almost all activities most of the day; significant weight
loss or weight gain; insomnia or hypersomnia nearly every day;
psychomotor agitation nearly every day; fatigue nearly every day;
feelings of worthlessness nearly every day; recurrent thoughts of death,
recurrent suicidal ideation without a plan, or a suicide attempt or a
specific plan



Treatment
o Treatment with an SSRI has been shown to be effective in treating postpartum
depression with minimal side effects and transfer through breastmilk
 Examples of SSRIs include escitalopram and sertraline
 Patient should be started on a low dose and the dose can be increased by the
provider as needed
o Alternative treatment options will be provided to patients such as therapy (CBT),
exercise, time for self, and support
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Patient should be referred out for CBT to a local therapist (a list of these will be
provided for office staff)
Examples of exercise can include walking, yoga, light weight training, swimming
once bleeding has ceased, and cycling



Follow up- for a patient who is diagnosed with postpartum depression and treatment has been
initiated, follow up should occur in 4 weeks



Risk for suicide
o Positive response to #10 on EPDS
o Suicidal thoughts
o Suicide plan, method, means to carry out plan
What to do when a patient is at risk for suicide
o Emergency psychiatric consult
o Activation of emergency services if a patient expresses she is suicidal and has expressed
that she has a method and a means to carry out suicide plan (calling for emergency
transportation to psychiatric unit/hospital)
How to assess for suicidal intent
o Ask patient at risk if she is currently thinking about or has recently thought about death
or harming herself
o Does the patient have a plan; if so ask the patient what her plan is
o Does the patient have access to the method (guns, pills, poison) if she has a current plan
and means
o Does the patient have intention of following through with plan
o Has the patient or a family member ever attempted suicide
o Is the patient currently using drugs or alcohol





Please call or text project leader, Mallory Matusik, with any questions at any time: (219) 484-7683

54
APPENDIX C
Protocol

TITLE: POSTPARTUM DEPRESSION
SCREENING AND FOLLOW UP

AUTHOR:

Mallory Matusik, RN,
BSN

DATE ORIGINATED: 7/21/2021

FRANCISCAN
APPLICABLE PHYSICIAN
TO:
NETWORK OBGYN
MUNSTER
DATE EFFECTIVE: 9/2021

POLICY STATEMENT/PURPOSE: to incorporate evidence-based practice for
screening and follow up of postpartum depression.
INDICATIONS: all women in the postpartum period at 2 or 6-weeks postpartum
EQUIPMENT: EPDS screening tool, paper form
PROCEDURE:
1. Screening
a. Receptionist gives patient consent form, demographic form, and
patient education handout
b. Receptionist gives participant EPDS paper form to fill out after
consent
c. RN enters results of EPDS into participant chart
d. Physician/nurse practitioner reviews results of EPDS with the
participant
e. Score of 10 or greater indicates positive screening result
2. Follow up for positive screening but no diagnosis of postpartum
depression
a. Educate participant on symptoms of postpartum depression and
suicidal thoughts/risk
i. Provide project participants with education handout
ii. Instruct participant to call the provider with symptoms of
postpartum depression and/or thoughts of suicide to arrange
for emergency referral to psychiatry
iii. Instruct the participant to call 911 if suicidal and has
intentions to carry out suicide plan
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3.

4.

5.

6.

b. Schedule follow up visit in 4 weeks for re-screening and
assessment
i. Score of 10 or greater on the EPDS at follow up visit
warrants diagnosis and treatment for postpartum depression
Diagnosing postpartum depression
a. Diagnosis made by provider based on clinical judgement, positive
screening, symptoms, and risk factors
i. Refer to DSM-5 criteria in provider education handout for
diagnosis
Treatment options for positive screening and diagnosis of postpartum
depression
a. Pharmacologic treatment
i. SSRI
1. Sertraline 50-200mg daily
a. Dose initially with 50mg/day and increase in 24 weeks if initial dose ineffective. Increase by
25-50mg every week with a max dose of
200mg/day
2. Escitalopram 10-20mg daily
a. Dose initially with 10mg/day and increase to
20mg/day after a minimum of 1 week
b. Alternative therapy
i. Cognitive behavioral therapy (CBT)
ii. Exercise
1. Walking, yoga, light weight training, swimming once
bleeding has ceased, and cycling
iii. Time for self
iv. Support from peers and family
v. Provide all participants with education handout with
information on alternative therapies
c. Referral
i. Referral for CBT
ii. Referral to mental health care provider after diagnosis
Follow up after diagnosis and treatment
a. Schedule follow up in 2 weeks after initiation of treatment or as
directed by the provider
Assessment of suicidal and/or homicidal ideation
a. Positive response on #10 on EPDS by participant
b. Assess risk of suicide
i. Suicidal thoughts
ii. Suicide plan, method, means to carry out plan
c. Assess participant and infant safety
d. Assess participant support system
e. Arrange for emergency psychiatric consult if having suicidal
thoughts or at risk
f. Assess need for activation of emergency services
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i. Participant has a suicide plan and has the means and the
intention to carry out plan
ii. Transfer to hospital/psychiatric unit
DOCUMENTATION:
1. EPDS score in patient chart
2. Patient reported symptoms of postpartum depression
3. Follow up visit if scheduled
4. Initiation of treatment or referral
5. Detailed encounter note of patient’s postpartum visit
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APPENDIX D
EPDS Tool
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APPENDIX E
GANTT Chart
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APPENDIX F
Demographic Form

Patient name:
Age:
Education level
 less than high school diploma

 some college

 high school

 college degree

Job status
 employed full time

 self employed

 employed part time

 not employed

Race/ethnicity
 African American

 White

 Hispanic

 Asian

 American Indian

 Other:

Marital status
 married

 single

 divorced

 widowed

Social history
 smoker

 alcohol use

 history of depression

 drug use

 family history of mental illness

 history of other mental illness (please list):

 none
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APPENDIX G
Clinic Flyer for Project Sustainability

HAVE YOU COMPLETED
YOUR POSTPARTUM
DEPRESSION
SCREENING?
Ask the front desk or your provider about screening
for postpartum depression with the EPDS tool today!

